Vysokodávkovaná chemoterapie s autologní transplantací při léčbě mnohočetného myelomu - přehled moderních léčebných možností

Title in English High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma-review of contemporary possibilities
Authors

RÁČIL Zdeněk ADAM Zdeněk HÁJEK Roman TOMÍŠKA Miroslav KREJČÍ Marta KŘIVANOVÁ Andrea HÖKLOVÁ Jana DOUBEK Michael MAYER Jiří VORLÍČEK Jiří

Year of publication 2001
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords multiple myleoma; chemotherapy
Description High-dosage chemotherapy with autologous transplantation of haematopietic stem cells prolonged the survival of patients with multiple myeloma as compared with results of standard chemotherapy, on average by 1.5 years. Nowadays this method is the standard treatment for suitable patients. Findings assembled recently are discussed by the authors.

You are running an old browser version. We recommend updating your browser to its latest version.

More info